Evidence map›Paper›PMID 39067135›Full record

ArticleEBioMedicine2024

KIT in oocytes: a key factor for oocyte survival and reproductive lifespan.

Yi Luan, Wonmi So, Rosemary Dong, Amirhossein Abazarikia, So-Youn Kim

Abstract read
In one paragraph

Article in EBioMedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yi LuanOlson Centre for Women's Health, Department of Obstetrics and Gynaecology, College of Medicine, University of Nebraska Medical Centre, Omaha, NE, USA.
Wonmi SoOlson Centre for Women's Health, Department of Obstetrics and Gynaecology, College of Medicine, University of Nebraska Medical Centre, Omaha, NE, USA.
Rosemary DongOlson Centre for Women's Health, Department of Obstetrics and Gynaecology, College of Medicine, University of Nebraska Medical Centre, Omaha, NE, USA.
Amirhossein AbazarikiaOlson Centre for Women's Health, Department of Obstetrics and Gynaecology, College of Medicine, University of Nebraska Medical Centre, Omaha, NE, USA.
So-Youn KimOlson Centre for Women's Health, Department of Obstetrics and Gynaecology, College of Medicine, University of Nebraska Medical Centre, Omaha, NE, USA; Fred and Pamela Buffett Cancer Centre, University of Nebraska Medical Centre, Omaha, NE, USA. Electronic address: soyoun.kim@unmc.edu.

Funding

Development of mechanism-based ovarian reserve protecting adjuvant therapies against gonadotoxic therapeutic agentsR01HD096042 · NICHD · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI KIM, SO-YOUN · 2019 to 2023
$1.6M
NICHD NIH HHS R01 HD096042
6 · The paper itself

Abstract

backgroundThe KITL-KIT interaction is known as an important initiator in oocyte activation through the downstream pathway of PI3K-AKT-FOXO3 signalling. Previous studies utilising germ cell-specific Kit mutant knockin and kinase domain knockout models with Vasa-Cre suggested the crucial role of KIT in oocyte activation at the primordial follicle stage.

methodsWe utilised mice with complete postnatal deletion of KIT expression in oocytes via Gdf9-iCre and conducted analyses on ovarian follicle development, specific markers, hormone assays, and fertility outcomes.

findingsOur findings reveal contrasting phenotypes compared to previous mouse models with prenatal deletion of Kit. Specifically, postnatal deletion of Kit exhibit no defects in germ cell nest breakdown, follicle activation, and folliculogenesis during development. Remarkably, upon reaching full maturity, mice with postnatal deletion of Kit experience a complete loss of ovarian reserve, growing follicles, and ovarian function. Furthermore, mice display smaller ovarian size and weight, delayed folliculogenesis, and phenotypes indicative of primary ovarian insufficiency (POI), including elevated serum levels of FSH, reduced AMH, and absence of ovarian follicles, ultimately resulting in infertility. Additionally, the ovaries exhibit randomly distributed expression of granulosa and theca cell markers such as Inhibin α, ACVR2B, and LHR. Notably, there is the uncontrolled expression of p-SMAD3 and Ki67 throughout the ovarian sections, along with the widespread presence of luteinised stroma cells and cleaved Caspase-3-positive dying cells.

interpretationThese genetic studies underscore the indispensable role of KIT in oocytes for maintaining the survival of ovarian follicles and ensuring the reproductive lifespan.

fundingThis work was supported by National Institutes of Health grant R01HD096042 and startup funds from UNMC (S.Y.K.).

Indexed as

OocytesOvarian FollicleProto-Oncogene Proteins c-kitAnimalsBiomarkersCell SurvivalFemaleGrowth Differentiation Factor 9MiceMice, KnockoutPrimary Ovarian InsufficiencyReproductionBiomarkersGrowth Differentiation Factor 9Kit protein, mouseProto-Oncogene Proteins c-kitFolliculogenesisInfertilityKITOocytePrimary ovarian insufficiencySurvival

Identifiers

PMID39067135
PMCPMC11338130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.